Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Effrosyni Manali

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
ERJ Open Research|May 5, 2022
Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosisTheodoros Karampitsakos, Ourania Papaioannou, Ilias Dimeas, et al.
The European Respiratory Journal|June 6, 2024
ERS statement on transition of care in childhood interstitial lung diseasesPetr Pohunek, Effrosyni Manali, Susanne Vijverberg, et al.
Pediatric Pulmonology|January 1, 2023
Diffuse alveolar hemorrhage in children with interstitial lung disease: Determine etiologies!Katrin Knoflach, Christina Katharina Rapp, Nicolaus Schwerk, et al.
Respirology (Carlton, Vic.)|October 3, 2025
Molecular Investigation in Early-Onset Interstitial Lung Disease: Results From 699 Unrelated PatientsCamille Louvrier, Nadia Nathan, Vincent Cottin, et al.
The European Respiratory Journal|August 15, 2024
European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosisCormac McCarthy, Francesco Bonella, Marissa O'Callaghan, et al.
Diagnostics (Basel, Switzerland)|May 1, 2025
Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity PneumonitisMatthaios Katsaras, Vasilina Sotiropoulou, Effrosyni Manali, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|December 10, 2024
Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patientsOurania Kotsiou, Paraskevi Kirgou, Argyrios Tzouvelekis, et al.
Advances in Respiratory Medicine|September 8, 2021
Epidemiological characteristics and outcomes from 187 patients with COVID-19 admitted to 6 reference centers in Greece: an observational study during the first wave of the COVID-19 pandemicArgyris Tzouvelekis, Karolina Akinosoglou, Theodoros Karampitsakos, et al.
Advances in Respiratory Medicine|November 25, 2024
Beneficial Impact of Vaccination Against SARS-CoV-2 on the Mental Health of IPF PatientsIoannis Tomos, Andriana I Papaioannou, Zoe I Daniil, et al.
Respirology (Carlton, Vic.)|March 26, 2025
Impact of A Multidisciplinary Team Discussion for Genetic Lung FibrosisGiovanni Franco, Ibrahima Ba, Nadia Nathan, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
ERJ Open Research|May 5, 2022
Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosisTheodoros Karampitsakos, Ourania Papaioannou, Ilias Dimeas, et al.
The European Respiratory Journal|June 6, 2024
ERS statement on transition of care in childhood interstitial lung diseasesPetr Pohunek, Effrosyni Manali, Susanne Vijverberg, et al.
Pediatric Pulmonology|January 1, 2023
Diffuse alveolar hemorrhage in children with interstitial lung disease: Determine etiologies!Katrin Knoflach, Christina Katharina Rapp, Nicolaus Schwerk, et al.
Respirology (Carlton, Vic.)|October 3, 2025
Molecular Investigation in Early-Onset Interstitial Lung Disease: Results From 699 Unrelated PatientsCamille Louvrier, Nadia Nathan, Vincent Cottin, et al.
The European Respiratory Journal|August 15, 2024
European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosisCormac McCarthy, Francesco Bonella, Marissa O'Callaghan, et al.
Diagnostics (Basel, Switzerland)|May 1, 2025
Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity PneumonitisMatthaios Katsaras, Vasilina Sotiropoulou, Effrosyni Manali, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|December 10, 2024
Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patientsOurania Kotsiou, Paraskevi Kirgou, Argyrios Tzouvelekis, et al.
Advances in Respiratory Medicine|September 8, 2021
Epidemiological characteristics and outcomes from 187 patients with COVID-19 admitted to 6 reference centers in Greece: an observational study during the first wave of the COVID-19 pandemicArgyris Tzouvelekis, Karolina Akinosoglou, Theodoros Karampitsakos, et al.
Advances in Respiratory Medicine|November 25, 2024
Beneficial Impact of Vaccination Against SARS-CoV-2 on the Mental Health of IPF PatientsIoannis Tomos, Andriana I Papaioannou, Zoe I Daniil, et al.
Respirology (Carlton, Vic.)|March 26, 2025
Impact of A Multidisciplinary Team Discussion for Genetic Lung FibrosisGiovanni Franco, Ibrahima Ba, Nadia Nathan, et al.
Pageof 3